Who has invested in Cytek Biosciences?

BlackRock, Inc., Vanguard Group Inc. are named among the investors backing Cytek Biosciences.

Cytek Biosciences Funding: $445M Raised, Series D (2021)

Cytek Biosciences funding overview

Cytek Biosciences is based in Fremont, CA. Cytek Biosciences has raised $445M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series D announced in July 2021. The round record for Cytek Biosciences runs through 2021; nothing later has been disclosed. Investors on record include BlackRock, Inc., Vanguard Group Inc.. 2 distinct backers are named across the disclosed rounds.

Cytek Biosciences at a glance

Total raised: $445M
Latest round: Series D
Latest round date: July 2021
Headquarters: Fremont, CA
Notable investors: BlackRock, Inc., Vanguard Group Inc.

Frequently asked about Cytek Biosciences funding

How much has Cytek Biosciences raised?: Cytek Biosciences has raised $445M in total disclosed funding across the rounds on record.
Who has invested in Cytek Biosciences?: BlackRock, Inc., Vanguard Group Inc. are named among the investors backing Cytek Biosciences.
What was the latest Cytek Biosciences funding round?: The most recent disclosed round is a Series D, announced in July 2021.
Where is Cytek Biosciences based?: Cytek Biosciences is based in Fremont, CA.
When did Cytek Biosciences last raise?: The last disclosed Cytek Biosciences round closed in July 2021 at Series D.

Cytek Biosciences totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Fremont below to benchmark round size and investor mix.

Cytek Biosciences Funding: $445M Raised, Series D (2021)

Cytek Biosciences funding overview

Cytek Biosciences at a glance

Frequently asked about Cytek Biosciences funding

Companies related to Cytek Biosciences (18)

Browse related funding lists (3)